The effect of Dermoline-henna on dermatitis due to radiation therapy

Phase 3

Recruiting

• Conditions: Radiodermatitis.; Radiodermatitis, unspecified; L58.9

• Registration Number: IRCT20200115046144N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 March 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 92

Inclusion Criteria

Women with breast cancer undergoing radiotherapy
Age range 18-70 years
Grade 1 and 2 dermatitis
Women whose breast is preserved

Exclusion Criteria

Untreated ulcer or scar and bacterial cellulite
Diabetes, hypertension, collagen vascular disease, chronic skin diseases
Simultaneous chemotherapy
Grade 3 and higher dermatitis
Chest deformity

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Degree of dermatitis. Timepoint: 1 week after intervention,2week after intervention,3week after intervention,4week after intervention. Method of measurement: Criteria to determine the degree of dermatitis radiation Therapy Oncology Group (RTOG).

Secondary Outcome Measures

Name	Time	Method
Itching. Timepoint: 1 week after intervention,2week after intervention,3week after intervention,4week after intervention. Method of measurement: Questioning the patient using a researcher-made questionnaire.;Pain. Timepoint: 1 week after intervention,2week after intervention,3week after intervention,4week after intervention. Method of measurement: Questioning the patient using a researcher-made questionnaire.;Burning. Timepoint: 1 week after intervention,2week after intervention,3week after intervention,4week after intervention. Method of measurement: Questioning the patient using a researcher-made questionnaire.